Published in Kidney Int on March 01, 1986
Vasopressin resistance in chronic renal failure. Evidence for the role of decreased V2 receptor mRNA. J Clin Invest (1995) 0.85
Use of nicotinamide to treat hyperphosphatemia in dialysis patients. Drugs R D (2013) 0.78
Contextual poverty, nutrition, and chronic kidney disease. Adv Chronic Kidney Dis (2015) 0.75
Prevention of renoprival nephropathy. West J Med (1986) 0.75
A comparison of the long-term effects of lanthanum carbonate and calcium carbonate on the course of chronic renal failure in rats with adriamycin-induced nephropathy. PLoS One (2014) 0.75
Urinary phosphorus excretion per creatinine clearance as a prognostic marker for progression of chronic kidney disease: a retrospective cohort study. BMC Nephrol (2015) 0.75
Prevention of 11-deoxycorticosterone-salt-induced glomerular hypertrophy and glomerulosclerosis by dietary phosphate binder. Am J Pathol (1990) 0.75
Phosphate-Induced Renal Fibrosis Requires the Prolyl Isomerase Pin1. PLoS One (2016) 0.75
The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med (1998) 7.18
The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med (1976) 5.10
The human costs of tobacco use (1) N Engl J Med (1994) 3.24
Crystal structure of human chorionic gonadotropin. Nature (1994) 3.06
Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest (2001) 2.84
The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med (1990) 2.82
Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med (1985) 2.82
Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care (2000) 2.36
Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events. Kidney Int (2000) 2.30
Osmotic and nonosmotic control of vasopressin release. Am J Physiol (1979) 2.18
Urinary diagnostic indices in acute renal failure: a prospective study. Ann Intern Med (1978) 2.13
We're at war--but where are our troops? Hosp Pract (Off Ed) (1994) 2.01
The human costs of tobacco use (2) N Engl J Med (1994) 1.93
Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis (2000) 1.86
Evidence for an in vivo antagonism between vasopressin and prostaglandin in the mammalian kidney. J Clin Invest (1975) 1.85
Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1995) 1.81
Metabolism and toxicity of aluminum in renal failure. Am J Clin Nutr (1980) 1.78
Clinical assessment of extracellular fluid volume in hyponatremia. Am J Med (1987) 1.76
Soft tissue calcification in chronic dialysis patients. Am J Pathol (1977) 1.73
Mechanism of the antidiuretic effect associated with interruption of parasympathetic pathways. J Clin Invest (1972) 1.72
Effects of hematocrit on renal hemodynamics and sodium excretion in hydropenic and volume-expanded dogs. J Clin Invest (1970) 1.67
Nonoliguric acute renal failure. N Engl J Med (1977) 1.64
Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int (1998) 1.64
Unrecognized adult salicylate intoxication. Ann Intern Med (1976) 1.63
Preservation of function in experimental renal disease by dietary restriction of phosphate. N Engl J Med (1978) 1.63
Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1994) 1.61
Mechanism of antidiuretic effect of beta adrenergic stimulation. J Clin Invest (1972) 1.54
Pulmonary calcification in chronic dialysis patients. Clinical and pathologic studies. Ann Intern Med (1975) 1.51
Gastrointestinal absorption of aluminum from aluminum-containing antacids. N Engl J Med (1977) 1.51
Total-body magnesium excess in chronic renal failure. Lancet (1972) 1.50
Role of vasopressin in the impaired water excretion of glucocorticoid deficiency. Kidney Int (1980) 1.50
Postoperative hyponatremia. A prospective study. Arch Intern Med (1986) 1.50
Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. N Engl J Med (1981) 1.49
Microsequence analysis of peptides and proteins. V. Design and performance of a novel gas-liquid-solid phase instrument. Anal Biochem (1985) 1.48
Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. N Engl J Med (1982) 1.48
The effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a pooled analysis of individual-patient data from 11 randomized, controlled trials. Ann Intern Med (2001) 1.44
Reversible renal failure associated with angiotensin-converting enzyme inhibitors in polycystic kidney disease. Ann Intern Med (1991) 1.44
A fatal encephalopathy in chronic haemodialysis patients. Lancet (1976) 1.42
Endotoxemic renal failure in mice: Role of tumor necrosis factor independent of inducible nitric oxide synthase. Kidney Int (2001) 1.41
Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care (1996) 1.40
Echocardiographic findings in autosomal dominant polycystic kidney disease. N Engl J Med (1988) 1.40
Infusion of glycine does not attenuate in vivo ischemic acute renal failure in the rat. J Lab Clin Med (1993) 1.40
Health care reform at $2 a pack. Hosp Pract (Off Ed) (1993) 1.39
Parenteral drug products containing aluminum as an ingredient or a contaminant: response to FDA notice of intent. ASCN/ASPEN Working Group on Standards for Aluminum Content of Parenteral Nutrition Solutions. Am J Clin Nutr (1991) 1.39
Treatment of peritoneal dialysis related peritonitis--an Australian and New Zealand perspective. Aust N Z J Med (1999) 1.38
Histological quantitation of aluminum in iliac bone from patients with renal failure. J Lab Clin Med (1982) 1.37
Aseptic necrosis of bone following renal transplantation: experience in 194 transplant recipients and review of the literature. Medicine (Baltimore) (1978) 1.37
Left ventricular hypertrophy in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1997) 1.37
Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med (1998) 1.36
Predictive value of 72-hour blastomere cell number on blastocyst development and success of subsequent transfer based on the degree of blastocyst development. Fertil Steril (2000) 1.36
Resolution of hyperparathyroidism, renal osteodystrophy and metastatic calcification after renal homotransplantation. N Engl J Med (1968) 1.36
Renal structure and hypertension in autosomal dominant polycystic kidney disease. Kidney Int (1990) 1.36
Crystal structure of histidyl-tRNA synthetase from Escherichia coli complexed with histidyl-adenylate. EMBO J (1995) 1.35
Arterial calcification and pathology in uremic patients undergoing dialysis. Am J Med (1979) 1.34
Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis. Trans Am Soc Artif Intern Organs (1972) 1.34
Chronic membranous glomerulonephritis caused by hepatitis B antigen-antibody immune complexes. Ann Intern Med (1974) 1.34
Renal toxicity of phosphate in rats. Kidney Int (1980) 1.33
Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM. Am J Kidney Dis (1998) 1.32
Inhibition of DNA replication and induction of S phase cell cycle arrest by G-rich oligonucleotides. J Biol Chem (2001) 1.32
Renal tubular acidosis associated with toluene "sniffing". N Engl J Med (1974) 1.32
The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. N Engl J Med (1982) 1.30
Hypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects. J Am Soc Nephrol (2001) 1.29
Mechanism of effect of alpha adrenergic stimulation with norepinephrine on renal water excretion. J Clin Invest (1973) 1.28
Polyuria of thyrotoxicosis: downregulation of aquaporin water channels and increased solute excretion. Kidney Int (2007) 1.28
Hyponatremia in cirrhosis: from pathogenesis to treatment. Hepatology (1998) 1.27
Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy. Am J Physiol (1997) 1.26
Bone aluminum and histomorphometric features of renal osteodystrophy. J Clin Endocrinol Metab (1982) 1.26
Upregulation of aquaporin-2 water channel expression in chronic heart failure rat. J Clin Invest (1997) 1.25
Role of vasopressin in abnormal water excretion in cirrhotic patients. Ann Intern Med (1982) 1.24
Induction of monocyte chemoattractant protein-1 by albumin is mediated by nuclear factor kappaB in proximal tubule cells. J Am Soc Nephrol (1999) 1.24
In vivo effect of indomethacin to potentiate the renal medullary cyclic AMP response to vasopressin. J Clin Invest (1977) 1.24
The clinical utility of renal concentrating capacity in polycystic kidney disease. Kidney Int (1989) 1.24
Nature of soft tissue calcification in uremia. Kidney Int (1973) 1.23
Loop diuretic infusion increases thiazide-sensitive Na(+)/Cl(-)-cotransporter abundance: role of aldosterone. J Am Soc Nephrol (2001) 1.23
Extraosseous calcification. Evidence for abnormal pyrophosphate metabolism in uremia. J Clin Invest (1976) 1.21
Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J Am Soc Nephrol (1997) 1.20
Lipopolysaccharide-induced MCP-1 gene expression in rat tubular epithelial cells is nuclear factor-kappaB dependent. Kidney Int (2000) 1.20
Quantitative grading of a human blastocyst: optimal inner cell mass size and shape. Fertil Steril (2001) 1.20
Nitric oxide: a mediator in rat tubular hypoxia/reoxygenation injury. Proc Natl Acad Sci U S A (1994) 1.20
Downregulation of the calpain inhibitor protein calpastatin by caspases during renal ischemia-reperfusion. Am J Physiol Renal Physiol (2000) 1.18
Aluminum kinetics during hemodialysis. J Lab Clin Med (1978) 1.18
Diagnostic importance of an increased serum anion gap. N Engl J Med (1980) 1.18
Renal, metabolic, and circulatory responses to heat and exercise. Studies in military recruits during summer training, with implications for acute renal failure. Ann Intern Med (1970) 1.18
Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Card Fail (1998) 1.17
A comparison of day 5 and day 6 blastocyst transfers. Fertil Steril (2001) 1.16
Effect of beta-adrenergic blockade and inhibitors of angiotensin II and prostaglandins on renal autoregulation. Am J Physiol (1975) 1.16
Modulation of plasma and platelet vasopressin by cardiac function in patients with heart failure. Kidney Int (1986) 1.16
Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses of acute renal failure. J Clin Invest (1988) 1.15
Mechanism of suppression of vasopressin during alpha-adrenergic stimulation with norepinephrine. J Clin Invest (1974) 1.15
Mechanism of increased sodium reabsorption during propranolol administration. Circulation (1971) 1.14
Mechanism of effect of hypoxia on renal water excretion. J Clin Invest (1978) 1.14
Effects of vitamin D-induced chronic hypercalcemia on rat renal cortical plasma membranes and mitochondria. Am J Physiol (1987) 1.14
Evidence of aluminum loading in infants receiving intravenous therapy. N Engl J Med (1985) 1.13
Nuclear proteins. I. Electrophoretic comparison of mouse nucleoli, heterochromatin, euchromatin and contractile proteins. Exp Cell Res (1975) 1.13
Augmentation of wound healing using monochromatic infrared energy. Exploration of a new technology for wound management. Adv Wound Care (1999) 1.12
Sodium, potassium and water metabolism in the syndrome of inappropriate antidiuretic hormone secretion. Am J Med (1970) 1.12